Add to ORKGOver the past decade, concerns have been raised regardingthe safety of a variety of psychotropic medications in children and adolescents, the appropriate selection of patients for therapy, and the indications for cardiovascular monitor-ing. In 1999, concerns over potential cardiovascular effects of psychotropic drugs, especially tricyclic antidepressants1,2 but including stimulants, prompted the American Heart Associ-ation (AHA) scientific statement “Cardiovascular Monitorin
Prescriptions of psychotropic medications have become an important intervention for many children an...
ObjectiveThe number of children and adolescents (hereafter referred to as "children") who have been ...
In this chapter, we review the developmental considerations that are necessary when prescribing anti...
Over the past decade, concerns have been raised regardingthe safety of a variety of psychotropic med...
Reports of sudden deaths of children and adolescents treated with psychotropic medications have rais...
ABSTRACT The purpose of this article is to examine the association of adverse cardiovascular risks w...
Twenty-four pediatric studies, published from various centers between 1967 and 1996, involving 730 c...
Attention-deficit hyperactivity disorder (ADHD) is a common neurobehavioral disorder that is often t...
INTRODUCTION Despite the growing evidence base for psychotropic drug treatment in pediatric patie...
Psychotropic medications commonly used with children have been associated with side effects signific...
BACKGROUND: Psychostimulants and atomoxetine have been shown to increase blood pressure, heart rate,...
Background: Many consumers express concerns about the safety of psychotropic medication for young pe...
BACKGROUND: It is unclear how youth treated with antipsychotics are monitored. The purpose of this s...
BACKGROUND. Prescription rates of psychotropic drugs to US children, and average duration of use, ro...
Second-generation antipsychotics (SGA) are being used more often than ever before in children and ad...
Prescriptions of psychotropic medications have become an important intervention for many children an...
ObjectiveThe number of children and adolescents (hereafter referred to as "children") who have been ...
In this chapter, we review the developmental considerations that are necessary when prescribing anti...
Over the past decade, concerns have been raised regardingthe safety of a variety of psychotropic med...
Reports of sudden deaths of children and adolescents treated with psychotropic medications have rais...
ABSTRACT The purpose of this article is to examine the association of adverse cardiovascular risks w...
Twenty-four pediatric studies, published from various centers between 1967 and 1996, involving 730 c...
Attention-deficit hyperactivity disorder (ADHD) is a common neurobehavioral disorder that is often t...
INTRODUCTION Despite the growing evidence base for psychotropic drug treatment in pediatric patie...
Psychotropic medications commonly used with children have been associated with side effects signific...
BACKGROUND: Psychostimulants and atomoxetine have been shown to increase blood pressure, heart rate,...
Background: Many consumers express concerns about the safety of psychotropic medication for young pe...
BACKGROUND: It is unclear how youth treated with antipsychotics are monitored. The purpose of this s...
BACKGROUND. Prescription rates of psychotropic drugs to US children, and average duration of use, ro...
Second-generation antipsychotics (SGA) are being used more often than ever before in children and ad...
Prescriptions of psychotropic medications have become an important intervention for many children an...
ObjectiveThe number of children and adolescents (hereafter referred to as "children") who have been ...
In this chapter, we review the developmental considerations that are necessary when prescribing anti...